Your browser doesn't support javascript.
loading
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.
McKerrell, Thomas; Moreno, Thaidy; Ponstingl, Hannes; Bolli, Niccolo; Dias, João M L; Tischler, German; Colonna, Vincenza; Manasse, Bridget; Bench, Anthony; Bloxham, David; Herman, Bram; Fletcher, Danielle; Park, Naomi; Quail, Michael A; Manes, Nicla; Hodkinson, Clare; Baxter, Joanna; Sierra, Jorge; Foukaneli, Theodora; Warren, Alan J; Chi, Jianxiang; Costeas, Paul; Rad, Roland; Huntly, Brian; Grove, Carolyn; Ning, Zemin; Tyler-Smith, Chris; Varela, Ignacio; Scott, Mike; Nomdedeu, Josep; Mustonen, Ville; Vassiliou, George S.
Afiliación
  • McKerrell T; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
  • Moreno T; Instituto de Biomedicina y Biotecnología de Cantabria, Cantabria, Spain;
  • Ponstingl H; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Bolli N; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Division of Haematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy;
  • Dias JM; Cancer Molecular Diagnosis Laboratory, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom;
  • Tischler G; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Colonna V; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; National Research Council, Institute of Genetics and Biophysics, Naples, Italy;
  • Manasse B; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom;
  • Bench A; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom;
  • Bloxham D; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom;
  • Herman B; Agilent Technologies, Cheadle, United Kingdom;
  • Fletcher D; Agilent Technologies, Cheadle, United Kingdom;
  • Park N; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Quail MA; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Manes N; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
  • Hodkinson C; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
  • Baxter J; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
  • Sierra J; Department of Haematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain;
  • Foukaneli T; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom;
  • Warren AJ; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute for Medical Research, Cambridge, United Kingdom;
  • Chi J; The Center for the Study of Haematological Malignancies, Nicosia, Cyprus; The Karaiskakio Foundation, Nicosia, Cyprus;
  • Costeas P; The Center for the Study of Haematological Malignancies, Nicosia, Cyprus; The Karaiskakio Foundation, Nicosia, Cyprus;
  • Rad R; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany;
  • Huntly B; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute for Medical Research, Cambridge, United Kingdom;
  • Grove C; Department of Haematology, PathWest/Sir Charles Gairdner Hospital, Perth, Australia; and Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.
  • Ning Z; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Tyler-Smith C; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, Cantabria, Spain;
  • Scott M; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
  • Nomdedeu J; Department of Haematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain;
  • Mustonen V; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom;
  • Vassiliou GS; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Department of Haematology, Haemato-oncology Diagnostic Service, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;
Blood ; 128(1): e1-9, 2016 07 07.
Article en En | MEDLINE | ID: mdl-27121471
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide / Neoplasias Hematológicas / Genómica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide / Neoplasias Hematológicas / Genómica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article